Induced Pluripotent Stem Cell-Derived Neural Cells Survive and Mature in the Nonhuman Primate Brain

Cell Reports

Volumn 3, Issue 3, 2013, Pages 646-650

  Emborg, Marina E ^a,b   Liu, Yan ^c   Xi, Jiajie ^c   Zhang, Xiaoqing ^c   Yin, Yingnan ^c   Lu, Jianfeng ^c   Joers, Valerie ^a   Swanson, Christine ^a   Holden, James E ^a,b   Zhang, Su Chun ^b,c  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; GLIA; INFLAMMATORY CELL; NERVE CELL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PARKINSONISM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; ASTROCYTES; BRAIN; CELL DIFFERENTIATION; FEMALE; INDUCED PLURIPOTENT STEM CELLS; MACACA MULATTA; MPTP POISONING; NEURAL STEM CELLS; NEUROGLIA; NEURONS; OLIGODENDROGLIA;

MACACA MULATTA; PARKINSONIA; PRIMATES;

EID: 84875811124     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.02.016     Document Type: Article

References (29)

1. Brundin P., Barker R.A., Parmar M. Neural grafting in Parkinson's disease Problems and possibilities. Prog. Brain Res. 2010, 184:265-294.
2. Cooper O., Hargus G., Deleidi M., Blak A., Osborn T., Marlow E., Lee K., Levy A., Perez-Torres E., Yow A., Isacson O. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol. Cell. Neurosci. 2010, 45:258-266.
3. Deleidi M., Hargus G., Hallett P., Osborn T., Isacson O. Development of histocompatible primate-induced pluripotent stem cells for neural transplantation. Stem Cells 2011, 29:1052-1063.
4. Doi D., Morizane A., Kikuchi T., Onoe H., Hayashi T., Kawasaki T., Motono M., Sasai Y., Saiki H., Gomi M., et al. Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease. Stem Cells 2012, 30:935-945.
5. Emborg M.E., Ebert A.D., Moirano J., Peng S., Suzuki M., Capowski E., Joers V., Roitberg B.Z., Aebischer P., Svendsen C.N. GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys. Cell Transplant. 2008, 17:383-395.
6. Emborg M.E., Moirano J., Raschke J., Bondarenko V., Zufferey R., Peng S., Ebert A.D., Joers V., Roitberg B., Holden J.E., et al. Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiol. Dis. 2009, 36:303-311.
7. Emborg M.E., Zhang Z., Joers V.M., Brunner K., Bondarenko V., Ohshima S., Zhang S.C. Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys. Cell Transplant. 2012, Published online June 15, 2012. 10.3727/096368912X47144.
8. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 2001, 344:710-719.
9. Hargus G., Cooper O., Deleidi M., Levy A., Lee K., Marlow E., Yow A., Soldner F., Hockemeyer D., Hallett P.J., et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl. Acad. Sci. USA 2010, 107:15921-15926.
10. Hockemeyer D., Wang H., Kiani S., Lai C.S., Gao Q., Cassady J.P., Cost G.J., Zhang L., Santiago Y., Miller J.C., et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 2011, 29:731-734.
11. Hu B.Y., Du Z.W., Li X.J., Ayala M., Zhang S.C. Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 2009, 136:1443-1452.
12. Hu B.Y., Weick J.P., Yu J., Ma L.X., Zhang X.Q., Thomson J.A., Zhang S.C. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. USA 2010, 107:4335-4340.
13. Kirkeby A., Grealish S., Wolf D.A., Nelander J., Wood J., Lundblad M., Lindvall O., Parmar M. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 2012, 1:703-714.
14. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., Carrillo-Reid L., Auyeung G., Antonacci C., Buch A., et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
15. Liu H., Zhu F., Yong J., Zhang P., Hou P., Li H., Jiang W., Cai J., Liu M., Cui K., et al. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 2008, 3:587-590.
16. Mendez I., Sanchez-Pernaute R., Cooper O., Viñuela A., Ferrari D., Björklund L., Dagher A., Isacson O. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005, 128:1498-1510.
17. Okita K., Yamanaka S. Induced pluripotent stem cells: opportunities and challenges. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2011, 366:2198-2207.
18. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 2003, 54:403-414.
19. Pankratz M.T., Li X.J., Lavaute T.M., Lyons E.A., Chen X., Zhang S.C. Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 2007, 25:1511-1520.
20. Perrier A.L., Tabar V., Barberi T., Rubio M.E., Bruses J., Topf N., Harrison N.L., Studer L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2004, 101:12543-12548.
21. Redmond D.E., Weiss S., Elsworth J.D., Roth R.H., Wakeman D.R., Bjugstad K.B., Collier T.J., Blanchard B.C., Teng Y.D., Synder E.Y., Sladek J.R. Cellular repair in the parkinsonian nonhuman primate brain. Rejuvenation Res. 2010, 13:188-194.
22. Swanson C.R., Joers V., Bondarenko V., Brunner K., Simmons H.A., Ziegler T.E., Kemnitz J.W., Johnson J.A., Emborg M.E. The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J. Neuroinflammation 2011, 8:91.
23. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
24. Thomson J.A., Kalishman J., Golos T.G., Durning M., Harris C.P., Becker R.A., Hearn J.P. Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 1995, 92:7844-7848.
25. Xi J., Liu Y., Liu H., Chen H., Emborg M.E., Zhang S.C. Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells 2012, 30:1655-1663.
26. Xia X., Zhang Y., Zieth C.R., Zhang S.C. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 2007, 16:167-176.
27. Yan Y., Yang D., Zarnowska E.D., Du Z., Werbel B., Valliere C., Pearce R.A., Thomson J.A., Zhang S.C. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 2005, 23:781-790.
28. Yang D., Zhang Z.J., Oldenburg M., Ayala M., Zhang S.C. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 2008, 26:55-63.
29. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.